Trial Profile
Post-market Safety Reassessment of Ulinastatin for Injection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2020
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Pancreatitis; Vascular disorders
- Focus Adverse reactions
- Sponsors Guangdong Techpool Bio-Pharma
- 19 Apr 2018 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 16 Jan 2018 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 16 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.